You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials

Citation Tools

Article menu
Lung cancer
PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Meng X, Chen Y, Xing L, et al
PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials
BMJ Open Respiratory Research 2022;9:e001294. doi: 10.1136/bmjresp-2022-001294